Consultation Courses Coaching Blog About Contact

Welcome to Spirit Pharmacist

About Me

I envision a society in which access to psychedelic drugs in a variety of safe settings is available for purposes of psychospiritual well-being, personal development, ceremonial sacraments, and treatment of mental illness.

I strive to let my loves and passions guide my activity and provide the canvas my life is painted on. I hope this site can be of service to my vision as well as you.

Professionally, I was trained as a clinical psychiatric pharmacist and worked in academia for almost five years before dedicating myself to Spirit Pharmacist.

Today I provide psychopharmacology consulting, courses in psychedelic pharmacy, and a Member Resource and Support Program.

On a more personal note, I’m a lover of nature, exercise, music, and consciousness as well as being a father. I’m passionate about cognitive liberty, self-realization, and psychedelic drugs.

Benjamin Malcolm, Spirit Pharmacist

 

Why Psychedelic Education? Why Now?

 

Training, Education, and Certification

Certifications

  • Board Certified Psychiatric Pharmacist (BCPP) 2017-2022

  • Licensed pharmacist CA #70652 2014-2022

Post-Graduate Training

  • PGY-2 Residency, Psychiatric Pharmacy – University of California at San Diego, San Diego CA. 2016

  • PGY-1 Residency, Acute Care – Scripps Mercy Hospital, San Diego CA. 2015

Education

  • Doctorate of Pharmacy – Touro University California, Vallejo CA. 2014

  • Master of Public Health – Touro University California, Vallejo CA. 2014

  • Bachelor of Science in Pharmacology – University of California at Santa Barbara, Goleta CA. 2008

Media Features and Podcast Appearances

Click to watch or listen

Peer Reviewed Works

Hover over text and click for journal article homepages

Sarparast, A., Thomas, K., Malcolm, B. et al. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology 239, 1945–1976 (2022). https://doi.org/10.1007/s00213-022-06083-y

Malcolm B, Thomas K. Serotonin toxicity of serotonergic psychedelics. Psychopharmacology (Berl). 2021;10.1007/s00213-021-05876-x. doi:10.1007/s00213-021-05876-x

Thomas K, Malcolm B (2021) Ch. 22 Adverse Effects. Handbook of Medical Hallucinogens. Edited by Grigsby J and Grob C. Guilford Press. ISBN 9781462545445

Diab H, Malcolm BJ (2020) Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT), Journal of Psychoactive Drugs, DOI: 10.1080/02791072.2020.1847366

Galan DK, Ezeudu NE, Garcia J, Geronimo CA, Berry NM, Malcolm BJ (2020) Eucalyptol (1,8-cineole): an underutilized ally in respiratory disorders? Journal of Essential Oil Research

Aguilar M, Malcolm B. Effect of long-acting aripiprazole monohydrate on inpatient encounters: A retrospective mirror image study. Mental Health Clinician. 2019;9(4):258-62. DOI: 10.9740/mhc.2019.07.258

Thomas K, Malcolm BJ, Lastra D (2017). Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders. J Psychoactive Drugs: 1-10.

Malcolm B, Tallian K. Essential oil of lavender in anxiety disorders: Ready for prime time? Mental Health Clinician: July 2017, Vol. 7, No. 4, pp. 147-155.

Feifel D, Malcolm B, Boggie D, Lee K. Low-dose ketamine for treatment resistant depression in an academic clinical practice setting. Journal of Affective Disorders 2017;221:283-8.

Lee KC, Kim E, Kim J, Malcolm B, Kuo GM, Bird A, Feifel F; Development of an innovative adult attention-deficit hyperactivity disorder clinic. Mental Health Clinician 1 September 2020; 10 (5): 296–300. 

Malcolm BJ, Lee KC. Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness? Mental Health Clinician: January 2017, Vol. 7, No. 1, pp. 39-45.

Malcolm BJ (Pro). Should Medical Cannabis Administered by Inhalation Be Allowed for Hospitalized Patients? Can J Hosp Pharm. 2018 May-Jun;71(3):211-214. Epub 2018 Jun 28.

Malcolm BJ, Polanco M, Barsuglia J. Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine. J Psychoactive Drugs. 2018 Apr 2:1-10.

Malcolm BJ, Perry P, Yoshizuka K. Marijuana and Pharmacy Practice: A Call to Action. California Journal of Health-Systems Pharmacy. 2014 Sep-Oct. Vol. 26 No. 5. pp 139-145

Barsuglia, J. P., Polanco, M., Palmer, R., Malcolm, B. J., Kelmendi, B., & Calvey, T. A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder. In T. Calvey (Ed.), Progress in Brain Research. 2018 Vol. 242, pp. 121-158

Teaching Experience

 

Continuing Education

 

University Teaching

'Psych Block' - Western University of Health Sciences College of Pharmacy 2017-2021

Lecture Topics Delivered (~50 hours/year):

  • Review of Neuropharmacology
  • Review of Neuroanatomy
  • Introduction to Psychiatric Pharmacy
  • Mental Status Exam & Suicide Risk
  • Depressive Disorders
  • Anxiety Disorders including PTSD & OCD
  • Schizophrenia
  • Schizophrenia therapeutics simulation
  • Bipolar Disorders
  • Eating Disorders
  • Sleep-Wake Disorders
  • Substance Use Disorders
  • Opioid Use Disorder
  • Debate Facilitator: Controversies in Psychiatric Drugs